Log in to save to my catalogue

TFRC, associated with hypoxia and immune, is a prognostic factor and potential therapeutic target fo...

TFRC, associated with hypoxia and immune, is a prognostic factor and potential therapeutic target fo...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c49d82ba8ef34b2580377ee3c0075fab

TFRC, associated with hypoxia and immune, is a prognostic factor and potential therapeutic target for bladder cancer

About this item

Full title

TFRC, associated with hypoxia and immune, is a prognostic factor and potential therapeutic target for bladder cancer

Publisher

England: BioMed Central Ltd

Journal title

European journal of medical research, 2024-02, Vol.29 (1), p.112-112, Article 112

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Bladder cancer is a common malignancy of the urinary system, and the survival rate and recurrence rate of patients with muscular aggressive (MIBC) bladder cancer are not ideal. Hypoxia is a pathological process in which cells acquire special characteristics to adapt to anoxic environment, which can directly affect the proliferation, invasion and im...

Alternative Titles

Full title

TFRC, associated with hypoxia and immune, is a prognostic factor and potential therapeutic target for bladder cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c49d82ba8ef34b2580377ee3c0075fab

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c49d82ba8ef34b2580377ee3c0075fab

Other Identifiers

ISSN

2047-783X,0949-2321

E-ISSN

2047-783X

DOI

10.1186/s40001-024-01688-9

How to access this item